Raised $8m last quarter, spent some on acquisitions (more than half ?) and should have quite enough $$$ left to avoid a CR as revenues from first Uruguayan crop and Atlanta's nutraceuticals should come in by next quarter's end.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game